총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Intra-Cellular Therapies, Inc. (ITCI), 포함 9 건 매수 및 39 건 매도. 내부자 매수 총액은 $1.35M 내부자 매도 총액은 $33.64M.
최근 활동이 있는 주요 내부자에는 Riggs Rory B, Marcus Joel S, Van Nostrand Robert L. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — ITCI
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2025-04-02 |
Riggs Rory B |
Director |
주식 반환 |
131,512 |
$132.00 |
$17.36M |
- |
| 2025-04-02 |
Marcus Joel S |
Director |
주식 반환 |
10,000 |
$132.00 |
$1.32M |
- |
| 2025-04-02 |
Van Nostrand Robert L |
Director |
주식 반환 |
2,951 |
- |
- |
- |
| 2025-04-02 |
Halstead Michael |
President |
주식 반환 |
12,240 |
- |
- |
- |
| 2025-04-02 |
Mates Sharon |
Chairman and CEO |
주식 반환 |
34,970 |
- |
- |
- |
| 2025-04-02 |
Neumann Mark |
EVP, Chief Commercial Officer |
주식 반환 |
17,916 |
$56.73 |
$1.02M |
- |
| 2025-04-02 |
Narula Sanjeev |
Executive Vice President & CFO |
주식 반환 |
22,727 |
- |
- |
- |
| 2025-04-02 |
Durgam Suresh K. |
EVP, Chief Medical Officer |
주식 반환 |
53,967 |
$12.73 |
$687K |
- |
| 2025-04-02 |
Salas Eduardo Rene |
Director |
주식 반환 |
1,567 |
$132.00 |
$206.84K |
- |
| 2025-03-26 |
Mates Sharon |
Chairman and CEO |
증여 (수령) |
190,000 |
- |
- |
190,000 |
| 2025-03-10 |
Halstead Michael |
President |
옵션 행사 (매도) |
7,345 |
- |
- |
- |
| 2025-03-10 |
Mates Sharon |
Chairman and CEO |
옵션 행사 (매도) |
20,566 |
- |
- |
- |
| 2025-03-10 |
Neumann Mark |
EVP, Chief Commercial Officer |
옵션 행사 (매도) |
7,345 |
- |
- |
- |
| 2025-03-10 |
Durgam Suresh K. |
EVP, Chief Medical Officer |
옵션 행사 (매도) |
7,345 |
- |
- |
- |
| 2025-03-06 |
Halstead Michael |
President |
옵션 행사 (매도) |
13,133 |
- |
- |
13,133 |
| 2025-03-06 |
Mates Sharon |
Chairman and CEO |
옵션 행사 (매도) |
40,712 |
- |
- |
40,713 |
| 2025-03-06 |
Neumann Mark |
EVP, Chief Commercial Officer |
옵션 행사 (매도) |
13,133 |
- |
- |
13,133 |
| 2025-03-06 |
Durgam Suresh K. |
EVP, Chief Medical Officer |
옵션 행사 (매도) |
13,133 |
- |
- |
13,133 |
| 2025-03-01 |
Halstead Michael |
President |
RSU 원천징수 |
6,261 |
$128.20 |
$802.66K |
11,304 |
| 2025-03-01 |
Mates Sharon |
Chairman and CEO |
옵션 행사 (매도) |
34,969 |
- |
- |
69,940 |
| 2025-03-01 |
Neumann Mark |
EVP, Chief Commercial Officer |
옵션 행사 (매도) |
8,742 |
- |
- |
17,485 |
| 2025-03-01 |
Durgam Suresh K. |
EVP, Chief Medical Officer |
옵션 행사 (매도) |
8,742 |
- |
- |
17,485 |
| 2025-02-24 |
Marcus Joel S |
Director |
옵션 행사 (매도) |
7,009 |
$63.79 |
$447.1K |
- |
| 2025-02-03 |
Halstead Michael |
President |
RSU 부여 |
45,454 |
- |
- |
45,454 |
| 2025-02-03 |
Mates Sharon |
Chairman and CEO |
RSU 부여 |
121,212 |
- |
- |
121,212 |
| 2025-02-03 |
Neumann Mark |
EVP, Chief Commercial Officer |
RSU 부여 |
22,727 |
- |
- |
22,727 |
| 2025-02-03 |
Narula Sanjeev |
Executive Vice President & CFO |
RSU 부여 |
22,727 |
- |
- |
22,727 |
| 2025-02-03 |
Durgam Suresh K. |
EVP, Chief Medical Officer |
RSU 부여 |
24,621 |
- |
- |
24,621 |
| 2025-01-31 |
Halstead Michael |
President |
RSU 원천징수 |
5,691 |
$127.00 |
$722.76K |
5,326 |
| 2025-01-31 |
Mates Sharon |
Chairman and CEO |
RSU 원천징수 |
15,233 |
$127.00 |
$1.93M |
1,085,943 |
| 2025-01-31 |
Neumann Mark |
EVP, Chief Commercial Officer |
RSU 원천징수 |
4,729 |
$127.00 |
$600.58K |
35,988 |
| 2025-01-31 |
Durgam Suresh K. |
EVP, Chief Medical Officer |
RSU 원천징수 |
4,730 |
$127.00 |
$600.71K |
26,090 |
| 2024-12-31 |
Riggs Rory B |
Director |
RSU 부여 |
215 |
$83.52 |
$17.96K |
131,512 |
| 2024-12-05 |
Mates Sharon |
Chairman and CEO |
옵션 행사 (매도) |
51,697 |
$12.73 |
$658.1K |
- |
| 2024-12-04 |
Mates Sharon |
Chairman and CEO |
옵션 행사 (매도) |
51,000 |
$12.73 |
$649.23K |
51,697 |
| 2024-11-13 |
Halstead Michael |
President |
옵션 행사 (매도) |
18,714 |
$36.89 |
$690.36K |
- |
| 2024-11-12 |
Halstead Michael |
President |
옵션 행사 (매도) |
22,869 |
$23.94 |
$547.48K |
- |
| 2024-09-30 |
Riggs Rory B |
Director |
RSU 부여 |
246 |
$73.17 |
$18K |
117,108 |
| 2024-08-30 |
Mates Sharon |
Chairman and CEO |
옵션 행사 (매도) |
34,396 |
$12.73 |
$437.86K |
102,697 |
| 2024-08-29 |
Mates Sharon |
Chairman and CEO |
옵션 행사 (매도) |
35,604 |
$12.73 |
$453.24K |
137,093 |
| 2024-08-28 |
Mates Sharon |
Chairman and CEO |
옵션 행사 (매도) |
32,699 |
$17.57 |
$574.52K |
- |
| 2024-08-27 |
Mates Sharon |
Chairman and CEO |
옵션 행사 (매도) |
40,513 |
$17.57 |
$711.81K |
32,699 |
| 2024-08-26 |
Mates Sharon |
Chairman and CEO |
옵션 행사 (매도) |
22,713 |
$17.57 |
$399.07K |
73,212 |
| 2024-08-23 |
Mates Sharon |
Chairman and CEO |
옵션 행사 (매도) |
28,680 |
$17.57 |
$503.91K |
95,925 |
| 2024-08-22 |
Mates Sharon |
Chairman and CEO |
옵션 행사 (매도) |
39,380 |
$17.57 |
$691.91K |
124,605 |
| 2024-08-21 |
Mates Sharon |
Chairman and CEO |
옵션 행사 (매도) |
53,013 |
$17.57 |
$931.44K |
163,985 |
| 2024-08-16 |
Neumann Mark |
EVP, Chief Commercial Officer |
옵션 행사 (매도) |
18,714 |
$36.89 |
$690.36K |
- |
| 2024-08-12 |
Narula Sanjeev |
Officer |
알 수 없음 |
- |
- |
- |
- |
| 2024-08-12 |
Narula Sanjeev |
Executive Vice President & CFO |
RSU 부여 |
17,251 |
$74.90 |
$1.29M |
17,251 |
| 2024-06-28 |
Riggs Rory B |
Director |
RSU 부여 |
262 |
$68.49 |
$17.94K |
116,862 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료
